{"prompt": "['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 4 of 115', 'be included in a submission', 'to Japan Pharmaceuticals', 'and Medical Device', 'Agency (PMDA)', '2.0', 'Table 5: Noted the', 'Clarification', 'Dana Wigert, Sr. Prin. Clinical', 'complication definition', 'Research Specialist', 'may vary from study to', 'Fred Kueffer, Pr. Statistician', 'study', '2.0', 'Sections 14 and 20.2:', 'FDA feedback and consistent', 'Dana Wigert, Sr. Prin. Clinical', 'Added weekly and', 'with the 2012 HRS Expert', 'Research Specialist', 'symptom driven event', 'Consensus Statement on', 'Fred Kueffer, Pr. Statistician', 'monitoring', 'Catheter and Surgical Ablation', 'of AF', '2.0', 'Sections 7.2.1, 14.7 and', 'FDA feedback', 'Dana Wigert, Sr. Prin. Clinical', '18.3: Modified the', 'Research Specialist', 'antiarrhythmic dose', 'Fred Kueffer, Pr. Statistician', 'allowed after the blanking', 'period to historic', 'maximum', '2.0', 'Sections 7.2.1 and 18: 12- -', 'Aligns with standard practice', 'Dana Wigert, Sr. Prin. Clinical', 'lead ECGs need to', 'and FDA feedback', 'Research Specialist', 'demonstrate at least 10', 'Fred Kueffer, Pr. Statistician', 'seconds of an atrial', 'arrhythmia to be', 'considered a treatment', 'failure', '2.0', 'Section 8.2: Rationale was', 'Consistent with the addition of', 'Dana Wigert, Sr. Prin. Clinical', 'updated', 'a primary safety objective', 'Research Specialist', 'Fred Kueffer, Pr. Statistician', '2.0', 'Section 14.1: Added', 'Clarification', 'Dana Wigert, Sr. Prin. Clinical', 'review of symptoms', 'Research Specialist', 'suggestive of recurrent', 'Fred Kueffer, Pr. Statistician', 'AF/AT/AFL to the study', 'procedures and data', 'collection table', '2.0', 'Section 14.4: Added When', 'Clarification', 'Dana Wigert, Sr. Prin. Clinical', 'performed, the TEE should', 'Research Specialist', 'be occur within 1 day (on', 'Fred Kueffer, Pr. Statistician', 'the day of or within the day', 'prior to) the planned', 'ablation procedure', 'Version 4, 10NOVO016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 5 of 115', '2.0', 'Section 14.5.5: Require', 'FDA feedback', 'Dana Wigert, Sr. Prin. Clinical', 'CTI ablation if typical', 'Research Specialist', 'flutter has been', 'Fred Kueffer, Pr. Statistician', 'documented or was', 'induced. Recommend', 'induction if not in the', 'documented history.', '2.0', 'Sections 7.2.1, 7.2.3,', 'Allows for treatment of pre-', 'Dana Wigert, Sr. Prin. Clinical', '14.5.5, 14.8, 18.3, and', 'existing right atrial arrhythmias', 'Research Specialist', '18.5: removed the', 'that may contribute to the', 'Fred Kueffer, Pr. Statistician', 'limitation that only CTI', 'primary objective if left', 'ablations are allowed in the', 'untreated', 'right atrium', '2.0', 'Section 14.18: Added that', 'Compliance percentage will be', 'Dana Wigert, Sr. Prin. Clinical', 'a study deviation is not', 'managed by the core lab', 'Research Specialist', 'required if a subject', 'Fred Kueffer, Pr. Statistician', 'misses a weekly TTM', 'transmission.', '2.0', 'Section 17: Added that', 'To support adverse event', 'Dana Wigert, Sr. Prin. Clinical', 'associated imaging', 'adjudication', 'Research Specialist', 'studies may be requested,', 'Fred Kueffer, Pr. Statistician', 'if available, for all serious', 'adverse events with', 'possible relatedness to', 'the system or procedure', '2.0', 'Section 18: Provided', 'FDA feedback', 'Dana Wigert, Sr. Prin. Clinical', 'details regarding the', 'Research Specialist', 'determination of subjects', 'Fred Kueffer, Pr. Statistician', 'for data analysis', '2.0', 'Section 18.4: Provided', 'FDA feedback', 'Dana Wigert, Sr. Prin. Clinical', 'details on the Hommel', 'Research Specialist', 'stepwise procedure for', 'Fred Kueffer, Pr. Statistician', 'the secondary objectives', '2.0', 'Section 18.5: Stated that', 'FDA feedback', 'Dana Wigert, Sr. Prin. Clinical', 'ancillary objectives been', 'Research Specialist', 'defined to provide', 'Fred Kueffer, Pr. Statistician', 'additional information', 'about the performance of', 'the Arctic Front Advance', 'Cardiac CryoAblation', 'Catheter. No hypotheses', 'are defined for regulatory', 'or labeling purposes.', 'Version 4, 10NOVO016', 'Confidential']\n\n###\n\n", "completion": "END"}